Legal Representation
Attorney
Rita E. Kline
USPTO Deadlines
Next Deadline
1445 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-06-27)
Due Date
June 27, 2029
Grace Period Ends
December 27, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
36 events| Date | Code | Type | Description |
|---|---|---|---|
| Oct 24, 2023 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Sep 28, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Sep 27, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Sep 27, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Aug 2, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Aug 2, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Aug 2, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jun 27, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jun 27, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Apr 13, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB |
| Apr 11, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 11, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 6, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Apr 6, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Apr 6, 2023 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Apr 6, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Mar 22, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 22, 2023 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Mar 22, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Mar 8, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Mar 8, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Mar 8, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Mar 8, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Mar 8, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 23, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Feb 23, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 23, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 12, 2022 | RFNT | P | REFUSAL PROCESSED BY IB |
| Aug 24, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Aug 24, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Jul 30, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Jul 29, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jul 27, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 1, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Feb 25, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 24, 2022 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
Chemico-pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders; injectable pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders; injectable pharmaceutical solutions for medical purposes for treatment of tumor, immune, and metabolic related diseases and disorders; troche, namely, medicated lozenges; medicines based on biologically active substances for treatment of tumor, immune, and metabolic related diseases and disorders; blood substitutes for medical and veterinary use; medicines for human purposes for treatment of tumor, immune, and metabolic related diseases and disorders; drugs for medical purposes for treatment of tumor, immune, and metabolic related diseases and disorders; biological preparations for medical purposes for treatment of tumor, immune, and metabolic related diseases and disorders; stem cells for medical purposes; biochemical drug, namely, biochemical pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Translation
The English translation of "ADLAI" in the mark is "Gods is just". The word "NORTYE" has no meaning in a foreign language.
Classification
International Classes
005
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO